Loading...

Jody Corey-Bloom

Title(s)Emeritus Professor, Neurosciences
SchoolHealth Sciences
Address9500 Gilman Drive #0948
La Jolla CA 92093
Phone858-246-1288
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    UCSD Alzheimer's Disease Research Center P50
    NIH P50AG005131Apr 1, 1997 - Aug 31, 1989
    Role: Co-Investigator
    General Clinical Research Center
    NIH M01RR000827Jan 27, 1997 - Nov 30, 2010
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Brain ultrashort T2 component imaging using a short TR adiabatic inversion recovery prepared dual-echo ultrashort TE sequence with complex echo subtraction (STAIR-dUTE-ES). J Magn Reson. 2020 Dec 28; 323:106898. Ma YJ, Jang H, Wei Z, Wu M, Chang EY, Corey-Bloom J, Bydder GM, Du J. PMID: 33429170.
      View in: PubMed   Mentions:    Fields:    
    2. Central Cognitive Processing Speed Is an Early Marker of Huntington's Disease Onset. Mov Disord Clin Pract. 2021 Jan; 8(1):100-105. Corey-Bloom J, Williams ME, Beltran-Najera I, Mustafa AI, Snell CM, Castleton J, Smith H, Wright B, Gilbert PE. PMID: 33426164.
      View in: PubMed   Mentions:
    3. Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington's Disease Patients and Healthy Control Subjects. Int J Mol Sci. 2020 Sep 02; 21(17). Corey-Bloom J, Fischer RS, Kim A, Snell C, Parkin GM, Granger DA, Granger SW, Thomas EA. PMID: 32887270.
      View in: PubMed   Mentions:    Fields:    
    4. Myelin Imaging in Human Brain Using a Short Repetition Time Adiabatic Inversion Recovery Prepared Ultrashort Echo Time (STAIR-UTE) MRI Sequence in Multiple Sclerosis. Radiology. 2020 11; 297(2):392-404. PMID: 32779970.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. Volumetric imaging of myelin in vivo using 3D inversion recovery-prepared ultrashort echo time cones magnetic resonance imaging. NMR Biomed. 2020 10; 33(10):e4326. Ma YJ, Searleman AC, Jang H, Fan SJ, Wong J, Xue Y, Cai Z, Chang EY, Corey-Bloom J, Du J. PMID: 32691472.
      View in: PubMed   Mentions:    Fields:    
    6. Ultrashort echo time (UTE) magnetic resonance imaging of myelin: technical developments and challenges. Quant Imaging Med Surg. 2020 Jun; 10(6):1186-1203. Ma YJ, Jang H, Chang EY, Hiniker A, Head BP, Lee RR, Corey-Bloom J, Bydder GM, Du J. PMID: 32550129.
      View in: PubMed   Mentions:
    7. Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. Neurol Genet. 2020 Jun; 6(3):e430. Claassen DO, Corey-Bloom J, Dorsey ER, Edmondson M, Kostyk SK, LeDoux MS, Reilmann R, Rosas HD, Walker F, Wheelock V, Svrzikapa N, Longo KA, Goyal J, Hung S, Panzara MA. PMID: 32548276.
      View in: PubMed   Mentions:
    8. Inversion recovery zero echo time (IR-ZTE) imaging for direct myelin detection in human brain: a feasibility study. Quant Imaging Med Surg. 2020 May; 10(5):895-906. Jang H, Carl M, Ma Y, Searleman AC, Jerban S, Chang EY, Corey-Bloom J, Du J. PMID: 32489915.
      View in: PubMed   Mentions:
    9. Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington's Patients. Front Neurosci. 2020; 14:73. Corey-Bloom J, Haque A, Aboufadel S, Snell C, Fischer RS, Granger SW, Granger DA, Thomas EA. PMID: 32194366.
      View in: PubMed   Mentions:
    10. Identification of Subtle Verbal Memory Deficits in Premanifest Huntington Disease Using the California Verbal Learning Test. Cogn Behav Neurol. 2020 03; 33(1):16-22. Holden HM, Tierney SM, Graves LV, Beltran-Najera I, Woods SP, Snell CM, Delis DC, Corey-Bloom J, Gilbert PE. PMID: 32132399.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington's Disease Patients. Front Mol Neurosci. 2019; 12:335. Gutierrez A, Corey-Bloom J, Thomas EA, Desplats P. PMID: 32038165.
      View in: PubMed   Mentions:
    12. Improved volumetric myelin imaging in human brain using 3D dual echo inversion recovery-prepared UTE with complex echo subtraction. Magn Reson Med. 2020 04; 83(4):1168-1177. Jang H, Wei Z, Wu M, Ma YJ, Chang EY, Corey-Bloom J, Du J. PMID: 31746487.
      View in: PubMed   Mentions: 3     Fields:    
    13. Whole-Brain Myelin Imaging Using 3D Double-Echo Sliding Inversion Recovery Ultrashort Echo Time (DESIRE UTE) MRI. Radiology. 2020 02; 294(2):362-374. Ma YJ, Searleman AC, Jang H, Wong J, Chang EY, Corey-Bloom J, Bydder GM, Du J. PMID: 31746689.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    14. Inversion recovery UTE based volumetric myelin imaging in human brain using interleaved hybrid encoding. Magn Reson Med. 2020 03; 83(3):950-961. Jang H, Ma Y, Searleman AC, Carl M, Corey-Bloom J, Chang EY, Du J. PMID: 31532032.
      View in: PubMed   Mentions: 3     Fields:    
    15. Handwriting Movement Abnormalities in Symptomatic and Premanifest Huntington's Disease. Mov Disord Clin Pract. 2019 Sep; 6(7):586-592. Caligiuri M, Snell C, Park S, Corey-Bloom J. PMID: 31538093.
      View in: PubMed   Mentions:
    16. New Intrusion Analyses on the CVLT-3: Utility in Distinguishing the Memory Disorders of Alzheimer's versus Huntington's Disease. J Int Neuropsychol Soc. 2019 09; 25(8):878-883. Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Gilbert PE, Delis DC. PMID: 31060638.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Revisiting total recognition discriminability in Huntington's and Alzheimer's disease: New insights from the CVLT-3. Appl Neuropsychol Adult. 2019 May 06; 1-8. Graves LV, Simone S, Williams M, Courville T, Mattson SN, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE. PMID: 31060389.
      View in: PubMed   Mentions:    Fields:    
    18. New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease. J Int Neuropsychol Soc. 2018 09; 24(8):833-841. Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE. PMID: 30113280.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Salivary levels of total huntingtin are elevated in Huntington's disease patients. Sci Rep. 2018 05 09; 8(1):7371. Corey-Bloom J, Haque AS, Park S, Nathan AS, Baker RW, Thomas EA. PMID: 29743609.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 09; 25(5):767-782. PMID: 28857679.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy. Appl Neuropsychol Adult. 2019 Jan-Feb; 26(1):17-27. Doyle KL, Woods SP, McDonald CR, Leyden KM, Holden HM, E Morgan E, Gilbert PE, Corey-Bloom J. PMID: 28850256.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Beneficial effects of glatiramer acetate in Huntington's disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms. Brain Res. 2017 Oct 15; 1673:102-110. Corey-Bloom J, Aikin AM, Gutierrez AM, Nadhem JS, Howell TL, Thomas EA. PMID: 28823953.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    23. Inversion recovery ultrashort echo time magnetic resonance imaging: A method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain - A feasibility study. Magn Reson Imaging. 2017 05; 38:87-94. PMID: 28038965.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    24. Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment: Applicability for Alzheimer's and Huntington's Diseases. Am J Alzheimers Dis Other Demen. 2016 12; 31(8):658-663. PMID: 27678491.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Total recognition discriminability in Huntington's and Alzheimer's disease. J Clin Exp Neuropsychol. 2017 Mar; 39(2):120-130. PMID: 27441951.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies. Neuroimage. 2016 Aug 01; 136:37-44. PMID: 27155128.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    27. Obstructive Sleep Apnea and Cognition in Parkinson's disease. Sleep Med. 2016 05; 21:28-34. PMID: 27448468.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    28. Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease. J Huntingtons Dis. 2016; 5(1):91-6. PMID: 27003664.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Measurement of T1 of the ultrashort T2* components in white matter of the brain at 3T. PLoS One. 2014; 9(8):e103296. PMID: 25093859.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    30. Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms. Sleep Med. 2014 Aug; 15(8):959-66. PMID: 24938585.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    31. Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea. Sleep. 2014 Jan 01; 37(1):177-85. PMID: 24470706.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    32. Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease. J Huntingtons Dis. 2014; 3(3):311-6. PMID: 25300334.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    33. The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease. J Neuropsychol. 2015 Mar; 9(1):77-86. PMID: 24330469.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Effects of sleep disorders on the non-motor symptoms of Parkinson disease. J Clin Sleep Med. 2013 Nov 15; 9(11):1119-29. PMID: 24235892.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    35. Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner. Neuroimage. 2014 Feb 15; 87:32-41. PMID: 24188809.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    36. Proactive selective response suppression is implemented via the basal ganglia. J Neurosci. 2013 Aug 14; 33(33):13259-69. PMID: 23946385.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    37. Actigraphy for the assessment of sleep measures in Parkinson's disease. Sleep. 2013 Aug 01; 36(8):1209-17. PMID: 23904681.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    38. Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease. Mov Disord. 2013 Oct; 28(12):1744-7. PMID: 23798501.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan. Cogn Behav Neurol. 2013 Mar; 26(1):1-5. PMID: 23538566.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    40. Postural limits of stability in premanifest and manifest Huntington's disease. J Huntingtons Dis. 2013; 2(2):177-84. PMID: 25063514.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Difficulty modifying a sustained motor response in prodromal Huntington's disease. J Clin Exp Neuropsychol. 2013; 35(1):35-40. PMID: 23198997.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Changes on brief cognitive instruments over time in Parkinson's disease. Mov Disord. 2012 Aug; 27(9):1125-8. PMID: 22692724.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    43. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ. 2012 Jul 10; 184(10):1143-50. PMID: 22586334.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimals
    44. Treatment trials in aging and mild cognitive impairment. Curr Top Behav Neurosci. 2012; 10:347-56. PMID: 21786037.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    45. Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation. Mov Disord. 2011 Dec; 26(14):2544-51. PMID: 21932302.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    46. Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease. Neuroimage. 2012 Feb 01; 59(3):2452-63. Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB. PMID: 21945695.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    47. Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year. Mov Disord. 2011 Jul; 26(8):1481-8. Majid DS, Stoffers D, Sheldon S, Hamza S, Thompson WK, Goldstein J, Corey-Bloom J, Aron AR. PMID: 21484871.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    48. A comparison of two brief screening measures of cognitive impairment in Huntington's disease. Mov Disord. 2010 Oct 15; 25(13):2229-33. Mickes L, Jacobson M, Peavy G, Wixted JT, Lessig S, Goldstein JL, Corey-Bloom J. PMID: 20721924.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    49. Cognitive and functional decline in Huntington's disease: dementia criteria revisited. Mov Disord. 2010 Jul 15; 25(9):1163-9. Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J. PMID: 20629124.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    50. Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea. Sleep Med. 2009 Dec; 10(10):1101-6. Cooke JR, Ancoli-Israel S, Liu L, Loredo JS, Natarajan L, Palmer BS, He F, Corey-Bloom J. PMID: 19699148.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    51. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med. 2009 Aug 15; 5(4):305-9. Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S. PMID: 19968005.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    52. Temporal order memory deficits prior to clinical diagnosis in Huntington's disease. J Int Neuropsychol Soc. 2009 Sep; 15(5):662-70. Pirogovsky E, Goldstein J, Peavy G, Jacobson MW, Corey-Bloom J, Gilbert PE. PMID: 19635179.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    53. Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc. 2009 Nov; 15(6):890-7. Jak AJ, Urban S, McCauley A, Bangen KJ, Delano-Wood L, Corey-Bloom J, Bondi MW. PMID: 19570306.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    54. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry. 2009 May; 17(5):368-75. Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, Delis DC. PMID: 19390294.
      View in: PubMed   Mentions: 161     Fields:    Translation:Humans
    55. Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment. Int Rev Neurobiol. 2009; 84:81-103. Jak AJ, Bangen KJ, Wierenga CE, Delano-Wood L, Corey-Bloom J, Bondi MW. PMID: 19501714.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    56. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J Am Geriatr Soc. 2008 Nov; 56(11):2076-81. Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS. PMID: 18795985.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    57. The contribution of cognition and spasticity to driving performance in multiple sclerosis. Arch Phys Med Rehabil. 2008 Sep; 89(9):1753-8. Marcotte TD, Rosenthal TJ, Roberts E, Lampinen S, Scott JC, Allen RW, Corey-Bloom J. PMID: 18760160.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    58. Identifying the "source" of recognition memory deficits in patients with Huntington's disease or Alzheimer's disease: evidence from the CVLT-II. J Clin Exp Neuropsychol. 2008 May; 30(4):463-70. Fine EM, Delis DC, Wetter SR, Jacobson MW, Hamilton JM, Peavy G, Goldstein J, McDonald C, Corey-Bloom J, Bondi MW, Salmon DP. PMID: 18415887.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    59. Alzheimer's disease. Semin Neurol. 2007 Feb; 27(1):32-41. Yaari R, Corey-Bloom J. PMID: 17226739.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    60. Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea. Am J Geriatr Psychiatry. 2006 Feb; 14(2):176-80. Ayalon L, Ancoli-Israel S, Stepnowsky C, Marler M, Palmer BW, Liu L, Loredo JS, Corey-Bloom J, Greenfield D, Cooke J. PMID: 16473983.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    61. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging. 2007 Feb; 28(2):238-47. Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW. PMID: 16434125.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    62. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Drugs Aging. 2006; 23(6):503-11. Cooke JR, Loredo JS, Liu L, Marler M, Corey-Bloom J, Fiorentino L, Harrison T, Ancoli-Israel S. PMID: 16872233.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    63. The effect of sleep-disordered breathing on stages of sleep in patients with Alzheimer's disease. Behav Sleep Med. 2006; 4(4):219-27. Cooke JR, Liu L, Natarajan L, He F, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Greenfield D, Ancoli-Israel S. PMID: 17083302.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    64. Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia. J Int Neuropsychol Soc. 2005 Oct; 11(6):708-15. Delis DC, Wetter SR, Jacobson MW, Peavy G, Hamilton J, Gongvatana A, Kramer JH, Bondi MW, Corey-Bloom J, Salmon DP. PMID: 16248906.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    65. The relationship between dementia severity and rest/activity circadian rhythms. Neuropsychiatr Dis Treat. 2005 Jun; 1(2):155-63. Gehrman P, Marler M, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. PMID: 18568061.
      View in: PubMed   Mentions:
    66. The timing of activity rhythms in patients with dementia is related to survival. J Gerontol A Biol Sci Med Sci. 2004 Oct; 59(10):1050-5. Gehrman P, Marler M, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. PMID: 15528777.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    67. Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores. J Int Neuropsychol Soc. 2003 Jul; 9(5):783-95. Bondi MW, Houston WS, Salmon DP, Corey-Bloom J, Katzman R, Thal LJ, Delis DC. PMID: 12901784.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    68. Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry. 2003 Mar-Apr; 11(2):194-203. Ancoli-Israel S, Martin JL, Gehrman P, Shochat T, Corey-Bloom J, Marler M, Nolan S, Levi L. PMID: 12611749.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    69. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav Sleep Med. 2003; 1(1):22-36. Ancoli-Israel S, Gehrman P, Martin JL, Shochat T, Marler M, Corey-Bloom J, Levi L. PMID: 15600135.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    70. The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias. Int Psychogeriatr. 2002; 14 Suppl 1:51-75. Corey-Bloom J. PMID: 12636180.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    Jody's Networks
    Concepts (204)
    Derived automatically from this person's publications.
    _
    Co-Authors (52)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _